Skip to main
PHR

Phreesia Inc (PHR) Stock Forecast & Price Target

Phreesia Inc (PHR) Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 27%
Buy 33%
Hold 40%
Sell 0%
Strong Sell 0%

Bulls say

Phreesia is a rapidly growing company in the healthcare industry that provides an integrated platform to address crucial challenges in healthcare delivery. The company's strong focus on product innovation and reinvesting in their core business, while also paying down debt, positions them well for future growth. The recent launch of Provider Connect and impressive customer response showcases the potential for even further success in their life sciences sector. With a stable topline outlook and potential upside in the second half of the fiscal year, Phreesia appears to be executing against a lower bar and has potential for meaningful expansion in the coming years.

Bears say

Phreesia is a growing company with a unique platform that addresses key challenges in healthcare delivery. However, the recent trend of declining subscription revenue and lower guidance for network solutions growth raises concerns about the effectiveness of their strategy. Additionally, the risks associated with regulatory compliance, competition, and acquisition integration could impact the company's financial performance and growth potential. While the company is trading at a discount compared to its peers, their continued challenges and risks make investing in their stock a risky bet.

Phreesia Inc (PHR) has been analyzed by 15 analysts, with a consensus rating of Buy. 27% of analysts recommend a Strong Buy, 33% recommend Buy, 40% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Phreesia Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Phreesia Inc (PHR) Forecast

Analysts have given Phreesia Inc (PHR) a Buy based on their latest research and market trends.

According to 15 analysts, Phreesia Inc (PHR) has a Buy consensus rating as of Sep 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $14.13, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $14.13, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Phreesia Inc (PHR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.